This 90 minute training course will provide your company the opportunity for comprehensive understanding of the IMPD (Investigational Medicinal Product Dossier) and the structure and content differences between a EU CTA Application and an FDA IND Application. Additionally, this webinar covers many related processes sponsors will need to know, as they file for, conduct and close-out effective clinical studies in the U.S. and EU.
The Investigational Medicinal Product Dossier (IMPD): EU CTA vs. FDA IND: Comparing the Content and Agency Expectation - Webinar By GlobalCompliancePanel
17 January 2012, Wilmington, United States
Introduction
Venue
1000 N West Street | Suite 1200
1000 N West Street | Suite 1200, 1000 N West Street, DE, Suite 1200, Wilmington, 19801, United States
Useful links
Organised by
GlobalCompliancePanel
Contact information
Related events
7th International Conference on Nanomaterials Science and Mechanical Engineering
8 July 2025 08:00 - 11 July 2025 18:00, Aveiro, Portugal
Future Labs Live Basel
27 May 2025 09:00 - 28 May 2025 17:00, Basel, Switzerland
Drugging the Multimorbidity Associated with Ageing
17 January 2025 09:30-17:00, London, United Kingdom
21st RSC Nucleic Acids Forum 鈥� 2025
11 July 2025 10:00-18:00, London, United Kingdom
Search
Advertisement
Spotlight
Explore
Membership
